middle.news
Tissue Repair Advances Phase 3 Trial Amid Strong TR Pro+ Sales Surge
6:13pm on Sunday 1st of June, 2025 AEST
•
Biotechnology
Read Story
Tissue Repair Advances Phase 3 Trial Amid Strong TR Pro+ Sales Surge
6:13pm on Sunday 1st of June, 2025 AEST
Key Points
First patient randomised in TR987® Phase 3 trial despite enrollment delays
TR Pro+® sales up 35% in Q4 with over 270 clinics ordering
US$1 million investment in API manufacturing to support scale-up
Advanced discussions underway for Australian and New Zealand distribution partnerships
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Tissue Repair (ASX:TRP)
OPEN ARTICLE